Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Celiac Disease

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Celiac Disease in 1 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Celiac Disease: A malabsorption syndrome that is precipitated by the ingestion of foods containing GLUTEN, such as wheat, rye, and barley. It is characterized by INFLAMMATION of the SMALL INTESTINE, loss of MICROVILLI structure, failed INTESTINAL ABSORPTION, and MALNUTRITION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mazzarella, G1
Bergamo, P1
Maurano, F1
Luongo, D1
Rotondi Aufiero, V1
Bozzella, G1
Palmieri, G1
Troncone, R1
Auricchio, S1
David, C1
Rossi, M1

Other Studies

1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Celiac Disease

ArticleYear
Gliadin intake alters the small intestinal mucosa in indomethacin-treated HLA-DQ8 transgenic mice.
    American journal of physiology. Gastrointestinal and liver physiology, 2014, Aug-01, Volume: 307, Issue:3

    Topics: Animals; Apoptosis; Caspase 3; Celiac Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diseas

2014